Operating Groups and Divisions
Instruments and Medical
Lonny J. Carpenter – Group President
James N. Heath – President, Instruments
Bradford L. Saar – President, Medical
Orthopaedics
Michael P. Mogul – President
Spine and Endoscopy
Timothy J. Scannell – Group President
James R. Lawson, Jr. – President, Spine
William R. Enquist – Global President, Endoscopy
International
Andrew G. Fox-Smith – Group President
Patrick J. Beyer – President, EMEA
Xavier Berling – President, Japan
James L. Cunniff – President, Pacific
David Murphy – General Manager, Canada
Gabriel Bonaventura – General Manager, Latin America
Biotech and Osteosynthesis
James E. Kemler – Group President
David A. Renker – Acting General Manager, Biotech
Vivian Masson – President, Osteosynthesis
Other Information
Independent Registered Public Accounting Firm
Ernst & Young LLP, Grand Rapids, Michigan
Transfer Agent and Registrar
National City Bank, Cleveland, Ohio
Shareholders needing information regarding their certificates or dividends should contact:
National City Bank
Corporate Trust Operations
P.O. Box 92301
Cleveland, Ohio 44193-0900
800.622.6757
shareholder.inquiries@nationalcity.com
Investor Contact
Katherine A. Owen, Vice President, Strategy and Investor Relations
Business Development Contact
Bryant S. Zanko, Vice President, Business Development
Annual Meeting
The Annual Meeting of Shareholders of Stryker Corporation will be held at the Radisson Plaza Hotel and Suites at The Kalamazoo Center in Kalamazoo, Michigan, on Wednesday, April 29, 2009, at 2:00pm EST.
Form 10-K
The Company files a Form 10-K with the U.S. Securities and Exchange Commission. Shareholders wishing a copy of the 2008 report may obtain it free of charge at www.stryker.com or request it by writing to:
Investor Relations
Stryker Corporation
2825 Airview Boulevard
Kalamazoo, Michigan 49002
Stock Listing
The Company’s common stock is traded on the New York Stock Exchange under the symbol SYK.
Certifications
The Company has filed with the U.S. Securities and
Exchange Commission all required certifications of the Chief
Executive Officer (CEO), the Chief Financial Officer and the
Vice President, Finance of the Company regarding the quality
of Stryker’s public disclosures. In addition, Stryker’s CEO
submitted to the New York Stock Exchange (NYSE) the annual
CEO certification stating that he is not aware of any violation
by the Company of the NYSE’s corporate governance
listing standards.
Stryker's Equal Employment Opportunity Policy Statement
Stryker is committed to providing Equal Employment
Opportunity to all employees and applicants for employment
on the basis of skills and ability and without regard to race,
color, creed, religion, sex, age, disability, national origin,
ancestry, citizenship, armed forces service, marital or veteran
status, sexual orientation, or any other impermissible factor.
Our policy of Equal Opportunity and Affirmative Action
applies to all phases of the employment process including, but
not limited to, recruitment, selection, promotion, transfer,
demotion, layoff, termination, compensation, benefits, and
other terms and conditions of employment, and further
requires maintaining a work atmosphere free of bias, including
the prevention of harassment. Harassment includes, but is
not limited to, disparaging remarks, innuendoes, slurs,
demeaning written or graphic material, or demeaning physical
or verbal confrontations based on race, color, creed, religion,
sex, age, disability, national origin, ancestry, citizenship, armed
forces service, marital or veteran status, sexual orientation,
or any other impermissible factor. Harassment of any nature
is expressly prohibited at Stryker.
Trademarks
The following trademarks or service marks of Stryker
Corporation, its divisions, or other corporate affiliated entities
appear in this Report: 1188 HD, ABG, Accolade, Asnis,
Calstrux, CerviCore, CORE, Exeter, FlexiCore, Gamma3,
HydroSet, InTouch, Neptune, NRG, Omega3, OP-1,
PneumoSure, S3, Scorpio, SDC, Secur-Fit, SERFAS, Sightline,
SPS, Stryker, Sumex, SwitchPoint Infinity, T2, Triathlon,
Trident, Tritanium, VariAx, Vision Elect, X3, X8000, Xia. All
other trademarks are trademarks of their respective owners
or holders.
Not all products referenced within this report are approved or cleared for sale, distribution or use in the United States.